Home
Enveda Biosciences

Enveda Biosciences Market Share Analysis for May 2026

Health > Biotechnology and Pharmaceuticals

Domainenveda.com

Year Founded2019

Employees201 - 500

Annual Revenue--

Enveda Biosciences

Enveda Biosciences (including company regionals)

enveda.com

See more website traffic and engagement information

Total visits to Enveda Biosciences's top domains

Understand Enveda Biosciences market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

enveda.com44.2K

See more with Sales Intelligence

Avg. visit duration in Enveda Biosciences's top domains

Analyze Enveda Biosciences engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

enveda.com00:00:52

See more with Sales Intelligence

Avg. pageviews on Enveda Biosciences's top domains

See how Enveda Biosciences keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

enveda.com1.98

See more with Sales Intelligence

Enveda Biosciences top competitors by domain

Top similar sites in May 2026, ranked by their affinity

biopharmadive.comCompany NameBioPharma DiveEmployees51 - 200HQUnited States, Washington, WashingtonAnnual revenue$10M - $15MTotal visits176.3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Enveda Biosciences

These are the website technologies, by industry, used by Enveda Biosciences top domains

Advertising (5)

Google Adsense

Marketing (4)

Google Marketing Platform

Audio Video Media (3)

YouTube

Content Management System (3)

WordPress

More Technologies

10

See all

News & Signals from Enveda Biosciences

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsEnveda Therapeutics, Inc. is developing AI-driven mosquito insecticides for malaria control on Jun 22nd '26.Purdue and Enveda launch project to develop AI-driven mosquito insecticides for malaria control.

NewsPremjiinvest invested into Enveda Therapeutics, Inc. $150M in Series D on Sep 1st '25.Enveda recently raised a $150M Series D, led by Premji Invest, to advance its pipeline of first-in-class medicines into the clinic.